Researchers urge slow tapers in deprescribing study for pediatrics
The Brown University Child & Adolescent Psychopharmacology Update · 2026-05 · 28 (5) · 1-4
DOI: 10.1002/cpu.31059 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Brown University Child & Adolescent Psychopharmacology Update, online erschienen am 27.04.2026. Verfasst von Alison Knopf.
Abstract (Originalsprache)
Deprescribing antidepressants for children and adolescents should be guided by data as well as observation of the patient's relapse and withdrawal symptoms, according to a new study. Clinicians should also consider the pharmacokinetic and pharmacodynamic properties of medications, including when and how to initiate deprescribing, the researchers add. These considerations are critically important to the clinician‐family‐patient relationship.
Zitieren
APA
Knopf, A. (2026). Researchers urge slow tapers in deprescribing study for pediatrics. The Brown University Child & Adolescent Psychopharmacology Update, 28(5), 1-4. https://doi.org/10.1002/cpu.31059
Vancouver
Knopf A. Researchers urge slow tapers in deprescribing study for pediatrics. The Brown University Child & Adolescent Psychopharmacology Update. 2026;28(5):1-4. doi:10.1002/cpu.31059
BibTeX
@article{Knopf2026,
author = {Knopf, Alison},
title = {Researchers urge slow tapers in deprescribing study for pediatrics},
journal = {The Brown University Child & Adolescent Psychopharmacology Update},
year = {2026},
volume = {28},
number = {5},
pages = {1--4},
doi = {10.1002/cpu.31059}
}
EUVIMED